Annual Short Term Debt
$3.50 M
+$1.92 M+121.20%
31 December 2023
Summary:
Xeris Biopharma Holdings annual short term debt is currently $3.50 million, with the most recent change of +$1.92 million (+121.20%) on 31 December 2023. XERS annual short term debt is now at all-time high.XERS Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Short Term Debt
$21.10 M
+$15.79 M+297.57%
30 September 2024
Summary:
Xeris Biopharma Holdings quarterly short term debt is currently $21.10 million, with the most recent change of +$15.79 million (+297.57%) on 30 September 2024. Over the past year, it has increased by +$18.73 million (+791.76%). XERS quarterly short term debt is now -99.39% below its all-time high of $3.43 billion, reached on 31 March 2018.XERS Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
XERS Short Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +121.2% | +791.8% |
| 3 y3 years | - | - |
| 5 y5 years | - | - |
XERS Short Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | at high | ||
| 5 y | 5 years | at high | at high | ||
| alltime | all time | at high | -99.4% |
Xeris Biopharma Holdings Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $21.10 M(+297.6%) |
| June 2024 | - | $5.31 M(+14.8%) |
| Mar 2024 | - | $4.62 M(+32.3%) |
| Dec 2023 | $3.50 M(+121.2%) | $3.50 M(+47.7%) |
| Sept 2023 | - | $2.37 M(+22.3%) |
| June 2023 | - | $1.94 M(+33.6%) |
| Mar 2023 | - | $1.45 M(-8.4%) |
| Dec 2022 | $1.58 M | $1.58 M(+363.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $341.00 K(>+9900.0%) |
| Dec 2021 | $0.00 | $0.00(-100.0%) |
| June 2019 | - | $3.00 M(-99.9%) |
| Mar 2019 | - | $2.58 B(+18.2%) |
| Dec 2018 | - | $2.19 B(-29.1%) |
| Sept 2018 | - | $3.08 B(-0.3%) |
| June 2018 | - | $3.09 B(-9.8%) |
| Mar 2018 | - | $3.43 B(+43.7%) |
| Dec 2017 | - | $2.39 B |
FAQ
- What is Xeris Biopharma Holdings annual short term debt?
- What is the all time high annual short term debt for Xeris Biopharma Holdings?
- What is Xeris Biopharma Holdings annual short term debt year-on-year change?
- What is Xeris Biopharma Holdings quarterly short term debt?
- What is the all time high quarterly short term debt for Xeris Biopharma Holdings?
- What is Xeris Biopharma Holdings quarterly short term debt year-on-year change?
What is Xeris Biopharma Holdings annual short term debt?
The current annual short term debt of XERS is $3.50 M
What is the all time high annual short term debt for Xeris Biopharma Holdings?
Xeris Biopharma Holdings all-time high annual short term debt is $3.50 M
What is Xeris Biopharma Holdings annual short term debt year-on-year change?
Over the past year, XERS annual short term debt has changed by +$1.92 M (+121.20%)
What is Xeris Biopharma Holdings quarterly short term debt?
The current quarterly short term debt of XERS is $21.10 M
What is the all time high quarterly short term debt for Xeris Biopharma Holdings?
Xeris Biopharma Holdings all-time high quarterly short term debt is $3.43 B
What is Xeris Biopharma Holdings quarterly short term debt year-on-year change?
Over the past year, XERS quarterly short term debt has changed by +$18.73 M (+791.76%)